We are live on
!
Find out more
Cytokinetics
CYTK
CYTK
430 hedge funds and large institutions have $8.86B invested in Cytokinetics in 2025 Q4 according to their latest regulatory filings, with 105 funds opening new positions, 143 increasing their positions, 134 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
306% more call options, than puts
Call options by funds: $477M | Put options by funds: $118M
123% more first-time investments, than exits
New positions opened: 105 | Existing positions closed: 47
14% more capital invested
Capital invested by funds: $7.75B → $8.86B (+$1.12B)
13% more funds holding
Funds holding: 380 → 430 (+50)
7% more repeat investments, than reductions
Existing positions increased: 143 | Existing positions reduced: 134
3.7% less ownership
Funds ownership: 117.77% → 114.08% (-3.7%)
6% less funds holding in top 10
Funds holding in top 10: 16 → 15 (-1)
Holders
430
Holders Change
+50
Holders Change %
+13.16%
% of All Funds
5.23%
Holding in Top 10
15
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-6.25%
% of All Funds
0.18%
New
105
Increased
143
Reduced
134
Closed
47
Calls
$477M
Puts
$118M
Net Calls
+$360M
Net Calls Change
+$86.1M
Top Buyers
| 1 |
BlackRock
New York
|
+$54.1M |
| 2 |
Goldman Sachs
New York
|
+$45.8M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$32.9M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$32.9M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$28.5M |
Top Sellers
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$84.9M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$59.9M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$41.8M |
| 4 |
VPC
Vestal Point Capital
New York
|
-$39.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$29.3M |
